Task: Answer the multiple-choice question.
Query: Which drug exhibits a -29.864% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a NNC(=O)CN(CCc1ccccc1)S(=O)(=O)c1ccc(Cl)cc1
b CCCn1c(=O)c2ccccc2n2c(SCCOc3ccccc3F)nnc12
c Cn1c(=O)c2[nH]c(NCCCN3CCOCC3)nc2n(C)c1=O
Answer: b. CCCn1c(=O)c2ccccc2n2c(SCCOc3ccccc3F)nnc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(=O)c2ccccc2n2c(SCCOc3ccccc3F)nnc12
CCCn1c(=O)c2ccccc2n2c(SCCOc3ccccc3F)nnc12
1-[2-(2-fluorophenoxy)ethylsulfanyl]-4-propyl-[1,2,4]triazolo[4,3-a]quinazolin-5-one